503-222-1261 info@crgpdx.com

Gout Explore Study

This is a phase 4 study to evaluate the safety and efficacy of Lesinurad 200mg in combination with a Xanthine Oxidase Inhibitor (XOI), compared with an XOI alone, in subjects with gout and moderate kidney disease who have not achieved…

Read More